Genus is a global animal genetics company that supplies breeding animals, semen, embryos and related genetic improvement programs for pigs and cattle. Through ABS and PIC it serves commercial livestock producers seeking higher productivity, health traits and feed efficiency via elite genetics and data-driven selection. The business model centers on proprietary genetics, reproductive technology and long-term relationships with farms and integrators rather than commodity meat production.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 593.4 | — | 40.9 | — |
| 2023 | 689.7 | 16.2% | 33.3 | -18.6% |
| 2024 | 668.8 | -3% | 7.9 | -76.3% |
| 2025 | 672.8 | 0.6% | 19.3 | 144.3% |
All markets — KeepWinning global stock screener
Other companies on London Stock Exchange: Clarkson PLC (CKN), Currys plc (CURY), Coats Group plc (COA), Sirius Real Estate Limited (SRE), Bodycote plc (BOY), Fidelity Special Values Ord (FSV)